November 30, 2017 Vaccinex & Catalent Biologics to Collaborate on Antibody-Drug Conjugate Development November 30, 2017 Catalent Pharma Solutions and Vaccinex, Inc. recently announced an agreement to develop an antibody-drug conjugate (ADC) using Catalent’s proprietary SMARTag®...